Sanadelaslam S. A. El‐Hddad

Author

Also Known As

SANADELASLAM EL-HDDAD, Sanadelaslam El-Hddad, Sanadelaslam S. A. El-Hddad, Sanadelaslam S. A. El‐Hddad, Sanadelaslam S.A. El-Hddad

Publications

395

Citations

H-Index

Concepts

All Affiliations

Al-Azhar University Heliopolis University Omar Al-Mukhtar University Almaarefa University Assiut University

About

Sanadelaslam S. A. El‐Hddad is an author at Al-Azhar University specializing in medicine, drug discovery, and molecular docking.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	113
2	Pharmacology	2	2	113
3	Engineering	1	1	96
4	Biomolecular Engineering	1	1	96
5	Pathology	1	1	17

Sanadelaslam S. A. El‐Hddad

Publications

371

Citations

H-Index

Page 1

	Year	Citations
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Bioorganic Chemistry Molecular DockingMedicinal ChemistryEngineeringVegfr-2 EnzymeMedicine	2020	96
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Archiv der Pharmazie	2020	56
Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1<i>H</i>,3<i>H</i>)‐dione bearing different moieties as VEGFR‐2 inhibitors Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Archiv der Pharmazie	2020	54
Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists Mohamed A. Abdelgawad, Khaled El‐Adl, Sanadelaslam S. A. El‐Hddad, Pharmaceuticals	2022	48
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors Khaled El‐Adl, Helmy Sakr, Sanadelaslam S. A. El‐Hddad, Archiv der Pharmazie	2021	44
Five and six membered heterocyclic rings endowed with azobenzene as dual EGFR<sup>T790M</sup> and VEGFR-2 inhibitors: design, synthesis, <i>in silico</i> ADMET profile, molecular docking, dynamic simulation and anticancer evaluations Kurls E. Anwer, Sanadelaslam S. A. El‐Hddad, Nour E. A. Abd El‐Sattar, RSC Advances	2023	34
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment Noura S. Hanafy, Nada A. A. M. Aziz, Sanadelaslam S. A. El‐Hddad, Archiv der Pharmazie	2023	22
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations Abeer A. Mohamed, Sanadelaslam S. A. El‐Hddad, Ahmed K. B. Aljohani, Bioorganic Chemistry Molecular DockingMedicinal ChemistryEgfrt790m Dual InhibitorsNovel TherapyMedicine	2023	17

Page 1